Therefore, VPA may synergize with drugs used in the therapy of HER2-overexpressed BC, like anti-HER2 monoclonal antibodies or anthracycline and taxane-based neoadjuvant chemotherapy. The gene discussed is ERBB2; the disease is breast cancer.